Grants and Contributions

Encouraging vaccine confidence in Canada PromoScience grants support organizations with strong track records of science and/or health promotion to deliver evidence-based, vaccine-promoting information to key communities and groups and/or to build capacity in the community to promote confidence in vaccines.

Pilot Study To Assess Efficacy of a Novel DNA and RNAi Vaccine Against ISAV (Infectious Salmon Anemia virus) Infection in Atlantic Salmon (Salmo salar).

The Government of Prince Edward Island is requesting assistance from the Canadian Red Cross to support the Province’s vaccine roll out plan. Specifically, support is required with the personnel resource management and non-clinical personnel for five vaccination clinics on the island from March 29, 2021 until September 30, 2021, in order to facilitate administration of two doses of vaccine.

Project activities include: (1) providing basic health services, including vaccination, prenatal and postnatal care to vulnerable and at-risk people; (2) distributing essential medications and medical supplies to health facilities; and (3) strengthening health sector coordination and health information systems.

Development and implementation of CANImmunize ClinicFlow to support the COVID-19 vaccine rollout in Canada.

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.